4/A
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-15-058358
SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)
From the SEC's structured data for this filing
Trades in this filing
Hadas Nicole R. · SVP, General Counsel, Sec.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-04-02 | Sale : show line 1 in the form | −1,483 | $9.09 | $13,478 | 67,015 | D |
| Open-market sales · 1,483 sh · avg $9.09 · $13,478 | ||||||
Loading xslF345X03/doc4a.xml…